Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Probi AB
Probi Targets US Expansion With Vital Nutrients Investment
European Probiotics specialist Probi has acquired a stake in US supplements firm Vital Nutrients, in a deal which will see the companies collaborate on new product development.
Probi Probiotic Shown To Reduce Inflammation During Acute Stress
Probi's probiotic "significantly decreased" plasma levels of two inflammatory markers coupled to acute stress in study, with the firm planning further research into the gut-brain axis.
EU Business Round-Up: Probi Targets Acquisitions, Oystershell Heads To US, Doetsch Grether Inks Swiss Deal
Probiotics player Probi will use deals and organic growth to double its sales over five years; Belgium's Oysershell strikes deal with Bayer for head-lice brand; and Doetsch Grether acquires Swiss supplements firm Vita.
BioInvent CEO To Step Down And Seek Scientific Successor
With its focus firmly on oncology, the Swedish biotech, and its outgoing chief, believe the company now needs someone with more scientific skills in the CEO role.
- OTC, Consumer
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.